A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the ...

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...

The Knoxville Community Development Corporation broke ground on Phase 2 of the Transforming Western initiative Wednesday.

The FDA set a PDUFA date in late 2025 as ziftomenib led to significant disease response in patients with common subtype of ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic ...

At U.S. 27 and Rogers Road, $2.6 million in federal funding is being spent on a construction project that started in March in ...

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Sempra's Port Arthur Phase 2 project in Texas has won U.S. approval to export liquefied natural gas to markets in Europe and ...

Dart has awarded a 12-year contract to a local firm, Mofat Company Limited, to operate Phase II of the Bus Rapid Transit (BRT ...

Sempra (NYSE:SRE) said Thursday the U.S. Department of Energy issued a permit allowing its Port Arthur LNG Phase 2 ...